The sesquicentennial celebrations of the publication of "Alice's Adventures in Wonderland" and the structure of benzene offer a unique opportunity to develop a contemporary interpretation of aspects of Alice's adventures, illuminate the symbolism of benzene, and contextualize both with the globalization of coffee, transitioning to how the philosophy and sustainable practices of ecopharmacognosy may be applied to modulating approaches to the quality, safety, efficacy, and consistency (QSEC) of traditional medicines and dietary supplements through technology integration, thereby improving patient-centered health care.
"Everything's got a moral, if only you can find it." said the Duchess to Alice.
We begin our allegoric thoughts with Alice and Benzene. The year 2015 marks the sesquicentennial of two, apparently disparate, events. In 1865, August Kekulé published an iconic paper in French (for he was then a Professor in Ghent, Belgium) suggesting that the structure of benzene contained a six-membered ring of carbon atoms with alternating single and double bonds, each with an attached hydrogen [1, 2] . Describing the origin of his idea twentyfive years later, Kekulé indicated that the benzene ring shape had come to him from a dream of a snake seizing its own tail, mimicking the ancient Egyptian symbol, the ouroboros.
Coincidentally, at about the same time, across the North Sea in England, the Oxford University mathematician Charles Lutwidge Dodgson, writing under the pseudonym Lewis Carroll, was publishing the most famous and widely-translated "children's" books, "Alice's Adventures in Wonderland" and "Through the Looking Glass" [3] . The audacities of Kekulé's and Carroll's vivid imaginations have survived and thrived, and in 2015 are being celebrated following 150 years of global impact. Molecular architecture, rabbit holes, and dreams…… What can their connections be with our contemporary challenges in traditional medicine on this disappearing Earth? This brief contribution attempts to tie these two "events" together in an allegoric manner, offering a contemporary interpretation of aspects of Alice's adventures, and illuminating the symbolism of benzene, with a relationship to the globalization of coffee, and transitioning to the global need for the philosophy and practices of ecopharmacognosy as integral to a patient-centered approach for advancing the status of traditional medicines (TMs) in integrated health care systems.
Alice's story begins with curiosity after she meets the White Rabbit wearing a waistcoat and looking at a pocket watch ("..this watch is exactly two days slow."). As if on a shamanistic journey, she shrinks in size and follows him deep down a hidden hole into a world where her orderly, mundane, upper-class existence becomes completely discombobulated. Since the beginning of the industrial revolution about 260 years ago in England, we have inexorably descended our own "rabbit-hole", accelerating in the past 150 years, to our contemporary life on Earth. Aspects of that incredible progress make abundant sense, and the continuously evolving scientific realities have dramatically and spectacularly extended our human and technological capacities throughout all aspects of society, including the extension of life expectancy which has risen from 47 years in 1950-1955 to 69 years in 2005-2010 [4] . Alice in her "Wonderland" of endless surprises and quirks represents us in ours; the wholeness of the single human race in a continuously changing, almost unpredictable world. In that wondrous and alien world, she almost completely loses both her orientation and her power of independent decision-making. Her leader in the unexpected and bizarre environment of Wonderland is the White Rabbit; for us it is burgeoning technology. We are challenged to ask whether we have now lost control of the applicability of our technology over the past 150 years [5] , and the recent movie "Ex Machina", directed by Garland, provides a fascinatingly evocative and dramatic cautionary tale of creating truly humanistic, artificial intelligence systems as our pathway progresses. How did Alice get out of the deep rabbit hole and of Wonderland and return to her mundane and structured upper-class English life? She was woken up by a whirling pack of cards…..it was all a dream. Can we be awakened from our dream-like stupor and take charge of global health care for the majority? Or are we already too deeply somnolent and transfixed by our technological prowess to consider serving the minority?
One situational difference is that the rabbit-hole into which Alice fell was animalcreated, "zoogenic", whereas our "hole" is anthropogenic, a humancreated, altered environment. Alice didn't have to change her habits to restore balance to her environment; we must.
Benzene, a distillate of coal tar [6] , results from the decay, over hundreds of millions of years, of Earth's primordial forests. The availability and continued use of benzene as a synthetic precursor, and in gasoline fuels (at the 0.62% level in the US), epitomizes human civilization taking from the Earth, and not returning to the Earth. It recognizes our deep societal dependence on depleting Earth's finite gifts, such as coal and oil. Benzene is the synthetic base for styrene, phenol, nylon fibers, lubricants, dyes, detergents, drugs, and pesticides, etc. It is an integral (now essential) aspect of an evolving global lifestyle; one which has turned into a continuing destructive saga of the very source of everything that supports us. Ironically, like the ouruboros, we are continuously "eating" our own A similar dichotomy of philosophy and practice exists with coffee. The coffee bean (berry) is derived from either Coffea arabica L. or C. canephora Pierre ex A. Froehner (Rubiaceae). Beginning in Ethiopia in the 15 th century, and moving into Yemen [8] , and then to Arabia and Persia, coffee as a consumed beverage spread to Venice, where it was deemed a Christian drink by Pope Clement VIII in 1600. The first coffee house in England appeared in 1650, and within 25 years, 3,000 existed [9] . Brazil, where cultivation began in 1822, is by far the world's largest producer (33.1%). Coffee is now grown in more than 70 countries, and engages over 100 million people [8] . It is the second-most valuable commodity exported by developing countries [10] .
Coffee serves as a representative example of the philosophical culmination of the concept of transitioning a plant from the forest into a global commodity (globalization). The continued, expanding daily consumption of coffee by billions of people illuminates the underlying assumptions of the global evolution of coffee as the marketed beverage in four ways: i) that the coffee contents are of good quality and not contaminated; ii) that they are safe when taken on a chronic basis, iii) that they are effective on continued use, and iv) that they are consistent on a day-to-day basis. These are the fundamental principles of quality, safety, efficacy, and consistency (QSEC) which should, at the global level, underpin the sciences of patient-centered traditional medicines. In addition, because it has been globalized as a stimulant beverage over hundreds of years [9], coffee is produced in a sustainable, and in many places organic, manner, through widespread cultivation, at a level of approximately 12 billion pounds per year.
Coffee also serves as a classic example of a non-sustainable and controversial commodity. Because of issues related to the susceptibility of C. arabica to infestation, particularly by coffee leaf rust Hemileia vastatrix and the coffee berry borer beetle (Hypothenemus hampei), a variety of pesticides is required for cultivation. Growing in open-fields compared with shaded, under canopy, cultivation [11] , the need for extensive deforestation, as well as the extreme water requirements (est. 140 L) to produce the beans for one cup of coffee [12], provide important lessons through which to lessen the environmental impact as traditional medicines are transitioned into cultivated global commodities.
Alice, Benzene, and Coffee, each provide important background concepts as we look at the future development of traditional medicines. The last aspect to be introduced is the term "ecopharmacognosy", a word 25 years in development [13] over the course of numerous articles , including some on that precise topic [30, 32, 34] . "Pharmacognosy" is defined as "the study of biologically active natural products" [17] . Therein, the constituent sciences of pharmacognosy are unlimited by the source material (plant, marine, microbial, insect, mammalian, etc.), or the research area (information systems, botanical, analytical, chemical, biosynthetic, biological, pharmacological, clinical, economic, legal, regulatory, etc.). This inherently suggests that to be successful in bringing focus to the implications for, and outcomes of, pharmacognosy research, a highly integrated and collaborative approach is needed.
In London, in March 2012, the "State of the Planet Declaration" was promulgated by the "Planet under Pressure" Conference [35] . It sought support for a societal contract to encompass: i) global sustainability analyses based in science, ii) integrated, international, and solutions-oriented research, implemented and involving government, society, scientists, and the private sector, and iii) enhanced dialog on issues of global sustainability. More recently, in July 2015, the Rockefeller Foundation-Lancet Commission on planetary health released a report on Planetary Health [4] , calling for societies to "address the drivers of environmental change by promoting sustainable and equitable patterns of consumption, reducing population growth, and harnessing the power of technology for change."
As a series of global sciences requiring, as a fundamental aspect of success, the continuing availability and judicious use of natural resources, it was astounding and distressing to acknowledge that pharmacognosy and its practices had barely considered "sustainability" as a conscious and evident component in our daily scientific research ideas and practices. There was a discussion sponsored by the World Health Organization on the conservation of medicinal plants in 1988 [36] and more recently aspects of "sustainable medicines" were discussed [25] [26] [27] [28] ; the need for awareness is much greater. Based on this situation, it was deduced that the profile and consciousness of the environmental and sustainability issues surrounding TMs needed to be raised, and hence a new term to integrate philosophy and practice was developed.
Thus "ecopharmacognosy" was born and introduced at a scientific meeting in Lublin, Poland in May, 2012. It is defined as "the study of sustainable, biologically active natural products" [30, 32, 34] . It offers a philosophical approach and a system of practices which stresses environmental concerns in natural product research from the perspective of the types of materials which should be studied, to opportunities for changing the practices used for their botanical, chemical, biological, and clinical assessment, to assuring a high QSEC product for the patient and the practitioner. It also embraces aspects of naturally-resourced agricultural practices, and the development of marine, bacterial, and fungal systems for scientific and economic development.
This brief and somewhat droll essay will attempt to coalesce some of the most well-known quotes and concepts from Alice's Adventures in Wonderland (AAIW) as a personal allegory for the considered use of our natural resources, with a more eco-centric view of developing Earth's natural medicinal resources, considering the patient-centered view of coffee as a pathway to develop a broad vision for traditional medicine enhancement within more integrated health care systems. Perhaps for some readers who are not familiar with "Alice's Adventures in Wonderland" this may be initially confusing. ""Then you should say what you mean," the March Hare went on." I will.
We all are aware of the Doomsday clock…..since 1947 a philosophical construct which "indicates" how close Earth is to nuclear disaster, based on the levels of war and conflict in its various forms around the world, and since 2007 to the impending disaster from climate change. It is presently set at 11.57 pm [37] . When Alice first meets the White Rabbit in her real world, he is concerned about how late it is as he scurries off down the hole. The White Rabbit is OUR timepiece for getting things done in time (his watch is two days slow remember!), suggesting that we look now at how late it is becoming to restore our world towards a semblance of sanity. For the truth is, as the grinning Cheshire cat states, "We are all mad here", in the way we use Earth's resources.
Since 2000, the World Health Organization has been promoting the evidence-based assessment of traditional medicine practices [38] , and the Beijing Declaration of 2008 encouraged countries to: i) respect, preserve, and promote knowledge and practices of TM; ii) formulate national policies, regulations and standards, as part of integrated health systems to ensure the appropriate, safe and effective use of TMs, and iii) promote TM research and innovation [39] . Further support has come from "The Regional Strategy for Traditional Medicine in the Western Pacific (2011-2020)" [40] and the "WHO traditional medicine strategy: 2014-2023" [41] , which have also placed significant emphasis on the sustainability aspects of developing traditional medicines. These strategy documents challeng countries to introduce policies and practices which will ensure the availability and improve the status of TM in their respective healthcare systems, based on a continuum of evidence-based approaches, in order to narrow the overt gaps in health care practices.
The economic and health care outcome gaps between traditional medicine and allopathic medicine globally are vast [30, [42] [43] [44] [45] [46] [47] . The additional challenges for enhancing TM based on an evidencebased, patient-centered approach entail an exploration from a scientific perspective of the many myths which are associated with, and in some respects inhibit, unbiased TM research and development [32] [33] [34] , to address the desperate need for quality control systems for TMs [13, 29, 31, 33] , and to examine the profound necessity to assure the supply of critically-needed traditional medicines through sustainable sourcing [25, 26, 29, 32, 33] for the majority of patients in the world. That those situations even exist in the 21 st century reflect another deep-seated "madness", a failure to bring even a semblance of equality to our health-care priorities globally, and an irrational view of natural resource sustainability, namely, the enduring "myth" that the plants will always be there.
When we speak of "sustainable medicines", the reference is to both natural and synthetic medicinal agents [25] [26] [27] [28] . For the patient, accessibility to treatment is critical for healing, and must embrace both affordability and sustainability. In addition, the patient requirement is for a safe and effective regimen for healing; the source of the medicine is irrelevant. The costs of allopathic medicines have risen well beyond the index of inflation [48] . Stunningly, there are a number of medical treatment protocols which have been approved by the USFDA in recent years where the annual patient/insurance company cost is in excess of $200,000 [49] . Meanwhile, at the global level, we are unable to deliver the simple drug aspirin (at less than 5 cents per dose) to those in pain. Drug resistance against cancer chemotherapeutics, antibiotics, antimalarials, anti-AIDS, and other infectious diseases is increasing steadily, but is not being addressed as a priority by the global pharmaceutical drug companies for economic reasons. Similarly, systematic drug discovery for the global major killer diseases and for tropical (orphan) diseases is not on the radar of Big Pharma, or even WHO; although the Gates Foundation and a recent Drugs for Neglected Diseases Initiative (www.dndi.org) will hopefully be impactful over time. Typically, and quite absurdly, these health care issues have been deemed to be addressed by the countries where the disease is prevalent; a truly inhumane and unethical decision with unrealistic expectations when only a handful of countries has the capacity to "discover" new medicinal agents for therapeutic use. Their typical resource is their plants and the medicinal knowledge associated with them, accumulated over time.
Let us return to our allegoric tale and to the sustainability of plantbased traditional medicine systems. It is fascinating that the dodo is one of the animals mentioned and depicted in AAIW; speculated to be because of Do-do-Dodgson's stammer [3] . The dodo, endemic to Mauritius, in 1662 became the first recorded extinction of a species caused by the actions of humans. It serves here as a profound reminder of the fragility of nature, and of the facile detrimental outcomes of the irrational urge for human dominance over nature. Today, there is a global system in place actively reviewing and recording the status of disappearing animals, plants, and other species, under the auspices of the International Union for Conservation of Nature. On these Red Lists of threatened and endangered species are (as of 2011) an estimated 9,568 plants of 61,900 recognized medicinal plant species. One of the priority activities recommended by WHO [40, 41, 50] is for countries to invest in assessing the availability and projected future access and supply chain for the needed TMs for their respective systems; some have done so [51, 52] . In the former instance, 39 of the most widely-used medicinal plant species were classified as threatened.
The European Union has also recently issued a Red List of medicinal plants [53] . It was estimated that 31% of the medicinal plant species were in decline, principally due to wild-crafting.
The most powerful biological effects in AAIW are those produced by the mushroom, which is introduced to Alice by the caterpillar, who sits atop it, smoking a hookah. For us, Caterpillar is the local medicine practitioner, curandero, hakim, shaman, etc. The left part of the mushroom causes Alice to grow larger, while the right part causes her to diminish in size. She eats these parts in turn to "control" her height. The mushroom represents what in pharmacognosy are known to be the very powerful attributes of biologically active natural products; on one hand to promote disease, to cause profound toxicity, even death, and on the other to overcome toxicity, treat disease, and restore homeostasis.
The mushroom is also an allegory for the impact of what we ingest (physically and metaphorically) on global population dynamics. Over the past two centuries, humanity has been taking the left part of the mushroom, which has allowed the global population to grow larger (to 7.4 billion in 2015), stay healthier, have more mothers and children surviving, and to live longer. Disease, famine, war, natural events, and some naturally-derived products for male and female fertility regulation, and social and personal reassessments of family size have caused a modulated population growth, or even a diminishing population, as seem in countries like Russia, Japan, Germany, and Bulgaria [54].
Those are effects derived from the right part of the mushroom. The mushroom also suggests that, through nature, an acceptable balance for Earth's population can be found. It is distressingly clear that such a balanced view of humanity is not on the agenda of any of the major international agencies or religions at this time. Maybe their leaders have not yet met any White Rabbits with watches indicating how behind the current time they are! For the dream seems to be of an Earth filled beyond sustainable capacity with healthy people. In this regard, Caterpillar asks Alice, "What size do you want to be?" As a human species, what is our answer for Earth's population? We have already passed, or are close to passing, several tipping points for a sustainable population of Earth [55] [56] [57] , such is the measure of our "overshoot". This occurs when the population exceeds the carrying capacity that an environment can maintain indefinitely. Even optimistic estimates for what population Earth could support for extended periods are low (ca. 4 billion; passed in July, 1974) based on an ecological footprint, and much lower (ca. 1 billion; passed in August, 1804) based on a thermodynamic footprint [58] .
Alice takes the left part of the mushroom that makes her grow taller to a point where she completely fills the little room she is in and then can't move. "There's no room to grow up any more here" she Cordell cries out. Some of the major cities in the world (Beijing, Manila, Delhi, Sao Paolo, Dhaka) are like that now, houses are cramped, streets are thronged with people, cars cause endless traffic jams, and combined with industrialization, produce stunning levels of pollution, and in war zones, refugees live with many families to a single tent. Like Alice, we too are losing our freedom of movement. Earth's population is projected to rise to 10 billion by 2045. The oceans are rising, and are becoming distinctly more acidic, as a result of climate modulation (global warming) [59] [60] [61] . Major cities, such as Bangkok [62] and Venice [63] , are sinking at alarming rates, and the future fate of needed medicinal plants in low-lying regions of the world is poorly studied [64, 65] . We can all shed tears, buckets of them, as we travel and observe what has happened to the state of our planet in our lifetimes. So when Alice swims in the pool of her tears with the dormouse (now an endangered species in England, by the way) she does so reflecting our tears for our environmental and biodiversity losses, now, and for the future generations. In terms of health care and medicinal agents, there are no solutions at present for delivering traditional and synthetic medicines in a sustainable manner to this exploding patient base.
Interestingly, and as a slight diversion from the main discussion, there are a number of direct associations with pharmacognosy present in the original drawings for AAIW by John Tenniel. There is for example a foxglove depicted in the meeting with the Cheshire Cat, and also when Alice is carrying the piglet. Then there is the powerful mushroom upon which the caterpillar sits, and chamomile is also cited. There is also the reference to the children down a well living on treacle, which was originally an extract of medicinal plants. And there is the warning on the first bottle that Alice encounters which is labeled "Drink me". "Better read it first, for if one drinks too much from a bottle marked "Poison", it's almost certain to disagree with one sooner or later", says Alice. This is an admirable admonition (read the label!) to the patient taking any medicine, particularly one where the plant material is known to have toxic effects at higher doses. It is a reminder too that the notion of "more is better", does not apply to the dosing of traditional medicines, a topic in itself of great controversy. With the differential effects of the mushroom evident, the important relationship between stereochemistry (handedness) and biological activity is also raised, where one enantiomer may have a completely different, even opposite biological effect, than the other enantiomer [66] [67] [68] .
At one point in the narrative, Alice ponders the question, "What is a "mustard?" Is it a mineral, an animal, or a vegetable? A reasonable question for a young, sheltered girl from an "upstairs" environment, for which the answer is actually not trivial, beyond being "vegetable" [69] . Her question though is a reminder to consider, and be grateful for, the items in our daily lives which we take for granted, and which are derived from nature without us thinking about them. In a contemporary context, consider, for example, how many readers of this article are aware of the origins and processing of cochineal and its uses or its' potential for sustainable development to provide the natural rouges and lipsticks for the faces of an expanding world? [70, 71] .
Speaking of red, Alice witnesses the presaging of GMOs, for there in the garden are three playing cards (spades, of course) painting the white roses red at the behest of the Queen. Biotechnology has revealed approaches to a new scenario, where colors and biologically useful metabolites can be modulated and potentiated in biosynthetic terms, and deleterious compounds minimized or eliminated in content; a highly effective demonstration of the principles of ecopharmacognosy, since expensive methods of separation and purification can be reduced.
Gryphons (griffins) are, according to legend, half eagle, and half lion. They are characterized by their power, extreme alertness and being stirred into rapid and fatally aggressive action at the slightest sound or movement, so as to alert the community. In AAIW, Carroll's gryphon is dozing, in spite of everything going on around. In our allegory, this is a clear reference to our lack of awareness and active concern, of not seeing and hearing the long standing, and increasingly loud indications from Nature itself, and those humanistic scientists concerned about nature, that aggressive corrective action in our behavior is needed.
Perhaps the most relevant scene to Earth's contemporary situation in AAIW is the Mad Hatters' Tea Party, where the time never changes (it is always six o'clock, and thus the time for tea). At the tea party, the participants (the Mad Hatter, the March Hare, and Dormouse) move around the table at each tea time, and always a new tea service is used. It is a classic example of our profligate consumption, as we move around our substantially disposable, nonreusable world, and of how, only very slowly, is global thinking at the political level concerning the sustainability and re-using of our resources (washing the dishes in AAIW) evolving. This scene can also be viewed as illustrating that changing time, actually moving through time as the world turns, requires the continuous reassessment of the status quo, whereas if time stands still, so does the status quo. For traditional medicines, it is this very status quo situation, which must shift to a patient-centered perspective for the benefit of humanity; we are already two days too slow (!), and need to move to a different time where the product and science and technology coalesce for the benefit of the patient. We, in consideration of future generations, have to wake up, "smell the coffee", and change our habits and practices to improve the role of traditional medicine in global health care.
The Preamble to the Constitution of the World Health Organization [72] states that "the highest attainable standard of health is one of the fundamental rights of every human being without distinction of race, religion, political belief, economic or social condition". Only when a population is healthy and not ravaged by disease, whether acute (Ebola) or chronic (malaria), can social and economic development be linked to effective and appropriate resource use [73] . About 80% of the plant resources used for traditional medicines in commerce are wild-crafted, and many are typically offered in an open manner in a local market, with little or no quality control, marginal concerns for safety, and almost no consideration afforded as to the age of the plant, and its changing efficacy and consistency. For most of the population of the world, this scene is their primary health care status quo, and has been for at least 4,000 years since the times of the early Chinese and Persian physicians until the present day [28] . As a global natural product health care community, we should be deeply embarrassed and ashamed by this appalling patient care situation.
In developed countries, the status of a patient-centric system for dietary supplements and traditional medicines is no better (and in some respects is even worse). A recent action by the Attorney General for New York State offers a glimmer of hope that even in the United States, where dietary supplement quality control is notoriously poor, and that of traditional medicines even worse, positive movement is possible [74] . In this instance, four large companies, GNC, Walgreen's, Walmart, and Target, were determined (through some not particularly well-conducted science) to have sold fraudulent dietary supplements; indeed 80% of the
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Natural Product Communications Vol. 10 (12) 2015 2199 package contents were not as labeled. Stunningly, several industryrelated groups [75] , not the retailers, went on the defensive, rather than acknowledging that, irrespective of the quality of the science, this is a huge, long-standing, industry-wide issue. Numerous instances of fraud in dietary supplements have been identified recently [76] [77] [78] [79] [80] [81] [82] [83] . When products are recalled by the FDA, they may remain on the market for over four years and still contain synthetic adulterants, including those products from US manufacturers [84] . However, it seems unlikely that, absent US Congressional action, concerted industry reform in terms of research investment and an enhanced commitment to real quality control (QSEC) will follow voluntarily. The present system is based entirely on the trust between the manufacturer and the patient; a trust which is now essentially dissipated. From the patient perspective, the opportunity for the dietary supplement manufacturing industry to change effectively the status quo as an evidence-based commitment to US patient health care has been lost. Similarly to when Alice is "lost" in Wonderland, the situation begs the very core question for the global traditional medicine and the dietary supplement industry:
"Would you tell me, please, which way I ought to go from here?" asked Alice. "That depends a good deal on where you want to get to," said the Cat.
Louis Sullivan, perhaps the most famous early American architect, who was based in Chicago, wrote, in an essay in 1896 concerning the design of tall buildings, that "….form ever follows function. That is the law." [85] . In practical terms, therefore, know what the building is for, and then design its form to meet the functional requirements. So what then is to be the perceived function of (eco)pharmacognosy? For what, as a conglomeration of diverse and integrated scientific applications, will it accept responsibility in terms of meeting the needs of those patients who choose to take natural products for their health care? Will it redefine itself, as this author has urged for more than 25 years, or will it forever be engulfed at the junction of status quo and societal health care responsibility; frozen at, indeed by, the abyss of change?
Traditional medicines, TM practitioners, and their patients around the world are in a state of deep flux, moving down the long pathway of information and experimentation from an inherently knowledgebased system, to an experience-based system, and eventually to an evidence-based system. It is well-known that the existing frameworks for the development, regulation, quality control, and sale of traditional medicines, dietary supplements and phytotherapeuticals, in spite of burgeoning sales, are not scientifically or societally acceptable because they are not patientcentered. The patient, who we as individuals all are, should be assured of the continued availability of quality, safe, effective, consistent (QSEC), and affordable traditional medicine products based on the results of evidence-based research and sustainability.
In the mid-1950s, before the global Japanese brands were renowned for their product quality, W. Edwards Deming, an American management expert, introduced a focus on continuous quality improvement to enhance the performance and product quality of Japanese industry [86] . One of his aphorisms from that time is "Quality begins with intent". Another dictum is that "We have lived in a world…… of defective products. It is time to adopt a new philosophy." [86] . In terms of the global quality control of traditional medicines and dietary supplements, we are still stuck living in a time of defective products. Moreover, the manufacturing industry, as the New York case showed, cannot grasp that it is their responsibility to change voluntarily their practices and their products to lead the improvements that are anticipated by the patient. The status quo places the patient in the unacceptable position of "buyer beware", with no reliable resources to consult. Now is indeed the time for a new philosophy, a new intent for the quality of traditional medicines and dietary supplements; the existing paradigm must change [13, 28, 29, 31, 32, 33] . The patient must be assured of QSEC in a trustworthy product as an essential moral and ethical responsibility. Less than that is an ethical misstep by the manufacturer, the provider, and a moral dilemma for the practitioner. Therefore, evidence-based research, focused on the development of sustainably-resourced, standardized traditional medicines and dietary supplements, as well as those essential oils used in aromatherapy and cosmeceutical products, is fundamental. In this way, appropriate biological and clinical studies can be conducted for the health benefit of the patient, and the assurances of the practitioner. There is a need also to label products, in an appropriate manner, to reflect the standards being applied to placing the product in the market place, and how sustainable is its sourcing.
There are numerous practical examples of ecopharmacognosy. Long-term resourcing of traditional medicines (and those for drug discovery) is an early stage development question. Consideration of a bark or a root material offers very different long-term challenges for sustainability than the corresponding development of a leaf or fruit. Following the principles of "green chemistry", ecopharmacognosy could embrace six applicable and practical principles [26, 87] , so that the global use of plants in traditional medicine can transition a "forest economy" to a "field economy", just as coffee has done [88] [89] [90] [91] [92] [93] [94] [95] . Some other examples of the practical application of ecopharmacognosy include: i) the improved use of information systems to delineate what has been done and what needs to be done (not wasting resources by reinventing the wheel!); ii) reducing the energy requirements for plant material extraction; iii) reducing the reliance on non-recyclable chromatographic supports and solvents; iv) determining the significance of individual plants in complex plant matrices to conserve species use; v) using network pharmacology [96, 97] to develop new uses for established and sustainable plants, vi) studying the waste products of the industrial processing of plants for new applications; vii) developing natural pesticides and insecticides from renewable resources, viii) assessing whole organisms, plants, and microbial systems as renewable catalytic reagents showing high yield and high enantioselectivity for organic chemical processes [98] [99] [100] [101] ; ix) re-energizing the development of natural dyestuffs from sustainable resources; and x) investigating well-established commercial crops, such as turmeric, ginger, oregano, garlic, cinnamon, caraway, etc. for new biological responses. One recent study found that an aqueous extract of caraway seed could have an obesity-reducing effect [102, 103] . Finally, microfluidic, lab-on-achip approaches to the chemical and biological assessment of plant samples in the field (previously referred to as "pharmacognosy in a suitcase") [25-27, 29, 30, 34] would save significantly on the drying, transportation, and macro-analytic processes required to evaluate the optimal time for accessing plant materials for therapeutic purposes based on the levels of their bioactive agents. Similarly, hyperspectral imaging using drone technology and/or remote sensing devices based on Raman technology could play a significant role in the field determination of important biological molecules, as has already been achieved with collagen [104, 105] .
Conclusions
Using the allegories based on Alice's Adventures in Wonderland, the dreamt discovery of the structure of benzene, and the globalization of coffee, new insights regarding the future, evidencebased directions of traditional medicine, are presented from the perspective of patient needs and expectations.
